In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...

The Bulgarian Parliament has recently adopted an Act to amend and supplement the Bulgarian Commercial Act[1] implementing the ...

Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) announced Friday that an expert panel of the EU drug regulator, the European ...

The European Commission (EC) has adopted yesterday the fifth annual Work Programme under the European Defence Fund (EDF), allocating over €1 billion to defence collaborative research and development ...

The European Commission (EC) has presented data regarding several criminal proceedings linked to the enforcement of EU law, with Bulgaria involved in seven of these cases. In the realm of crime ...

The 25% tax that President Donald Trump plans to slap as soon as Saturday on imports from Canada and Mexico could drive up ...

The European medicines regulator said on Friday it will review safety information for Eisai and Biogen's Leqembi, nearly ...

The European Commission said on Friday that it has launched infringement procedures against Bulgaria for failing to fully ...

Amgen’s Blincyto (blinatumomab) has been approved by the European Commission (EC) to treat certain acute lymphoblastic ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission has asked the Committee for Medicinal Products for Human Use (CHMP) to consider two ...

Turkish Foreign Minister Hakan Fidan met in Ankara with the EU High Representative for Foreign Affairs and Security Policy, Kaja Kallas. During the press conference, both sides emphasised the ...

Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...